Scope of the Report
The report titled “Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020)”, provides and in-depth analysis of the global CINV market and respective drugs. The report gives an insight of the global CINV market by 5-HT3 and NK-1 drug receptor antagonists.
The report titled “Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020)”, provides and in-depth analysis of the global CINV market and respective drugs. The report gives an insight of the global CINV market by 5-HT3 and NK-1 drug receptor antagonists.
Purchase a copy of Global Chemotherapy Induced Nausea and Vomiting (CINV) Market visit @ http://www.orbisresearch.com/contact/purchase/185419
.
The
report also includes the analysis of North American CINV market. The report
also assesses the key opportunities in the market and outlines the factors that
are and will be driving the growth of the industry. Growth of the overall
global CINV market has also been forecasted for the period 2016-2020, taking
into consideration the previous growth patterns, the growth drivers and the
current and future trends.
The
competition in global CINV market is fragmented as the specific treatment for
CINV is still at a nascent stage with several drugs by multiple competitors
already thriving the market and some are under formulation.
The key
players of the global CINV market, Heron Therapeutics, Inc., Merck & Co.,
Inc., Novartis AG and TESARO, Inc. are also profiled with their financial
information and respective business strategies
Country Coverage
North America
North America
Company Coverage
Heron Therapeutics, Inc.
Merck & Co., Inc.
Novartis AG
TESARO, Inc.
Heron Therapeutics, Inc.
Merck & Co., Inc.
Novartis AG
TESARO, Inc.
Executive Summary
Chemotherapy induced nausea and vomiting (CINV) is the most dreaded side-effect of chemotherapy among the cancer patients. Therefore, sometimes patients either do not undergo the chemotherapy or discontinue in the prior year of treatment. CINV is also of various types such as acute, breakthrough, delayed, anticipatory and refractory. HEC and MEC regimens cause the CINV. Several treatments of CINV are on the verge of emergence such as 5-HT3 receptor antagonist, NK-1 blocker, corticosteroids, cannabinoids and dopamine antagonists. However, there are several unmet medical needs in the field of HEC regimen of delayed CINV.
Chemotherapy induced nausea and vomiting (CINV) is the most dreaded side-effect of chemotherapy among the cancer patients. Therefore, sometimes patients either do not undergo the chemotherapy or discontinue in the prior year of treatment. CINV is also of various types such as acute, breakthrough, delayed, anticipatory and refractory. HEC and MEC regimens cause the CINV. Several treatments of CINV are on the verge of emergence such as 5-HT3 receptor antagonist, NK-1 blocker, corticosteroids, cannabinoids and dopamine antagonists. However, there are several unmet medical needs in the field of HEC regimen of delayed CINV.
Get More Information of Global Chemotherapy Induced Nausea and Vomiting (CINV) Market Report @ http://www.orbisresearch.com/reports/index/global-chemotherapy-induced-nausea-and-vomiting-cinv-market-size-trends-and-forecasts-2016-2020
.
Global
CINV market has increased at a significant CAGR during the years 2013-2015 and
projections are made that the market would rise tremendously in the next four
years i.e. 2016-2020. The CINV market is expected to increase due to growth in
global cancer incidence, increasing health expenditure and the increasing
outbreak of factors working towards causing cancer. Yet, the market faces some
challenges such as discontinuation of chemotherapy treatment, several unmet
medical needs, no drugs for the HEC regimen in the delayed CINV, etc.
Some Points From List Of Tables:
Figure 1: Side-Effects of Chemotherapy
Figure 2: Delivery Methods of Chemotherapy
Figure 3: Types of Chemotherapy Drugs
Figure 4: Pros & Cons of Chemotherapy
Figure 5: Types of CINV
Figure 6: CINV Mechanism
Figure 7: Regimens Causing CINV
Figure 8: Treatment/Prevention of CINV
Figure 9: Global CINV Market Opportunity; 2015
Figure 10: Global CINV Market by Value; 2013-2015 (US$ Billion)
Figure 11: Global CINV Market by Value; 2016-2020 (US$ Billion)
Figure 2: Delivery Methods of Chemotherapy
Figure 3: Types of Chemotherapy Drugs
Figure 4: Pros & Cons of Chemotherapy
Figure 5: Types of CINV
Figure 6: CINV Mechanism
Figure 7: Regimens Causing CINV
Figure 8: Treatment/Prevention of CINV
Figure 9: Global CINV Market Opportunity; 2015
Figure 10: Global CINV Market by Value; 2013-2015 (US$ Billion)
Figure 11: Global CINV Market by Value; 2016-2020 (US$ Billion)
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment